CRESOME
Live / Applied — Opposition pending (as of 13 Jul 2026)
What this means for you
Not registered yet, but its 25 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers. An opposition to it is pending before the Trademark Trial and Appeal Board, so it will register only if the opposition fails or is withdrawn.
Record
- Serial number
- 79417679
- Mark type
- Word mark
- Filed
- 25 Nov 2024
- Published for opposition
- 20 Jan 2026
- Attorney of record
- JOSEPH R. DAGES
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; medical cardiovascular pharmaceuticals; cardiovascular pharmaceuticals; pharmaceuticals for the treatment of cardiovascular and cerebrovascular diseases; capsules sold empty for medicines; pharmaceutical preparations for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; pharmaceuticals for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; ointments for pharmaceutical purposes, namely, antibiotic ointments, anti-inflammatory ointment; biological preparations for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment; chemical preparations for medical purposes for the treatment of cardiovascular diseases, coronary artery disease, cerebrovascular diseases, peripheral vascular diseases, coronary atherosclerotic disease, erectile dysfunction, cognition impairment
Owner
Board proceedings on this mark
- Opposition No. 91308782 — Astellas US LLC v. Beijing Inno Medicine Co., Ltd., filed 09 Jul 2026 (Suspended)
- Extension of Time to Oppose No. 79417679 — Astellas US LLC v. BEIJING INNO MEDICINE CO., LTD., filed 17 Feb 2026 (Terminated)
Prosecution history
- 13 Aug 2026 — REFUSAL PROCESSED BY IB
- 13 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 27 Jul 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 26 Jul 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 19 Jul 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 13 Jul 2026 — OPPOSITION INSTITUTED NO. 999999
- 10 Jul 2026 — OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
- 10 Jul 2026 — OPPOSITION NOTICE (IB REFUSAL) CREATED
- 17 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE